{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:59:39Z","timestamp":1790643579361,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"DOI":"10.1038\/s41375-026-03140-9","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:55:56Z","timestamp":1790596556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and molecular characteristics of clonal monocytosis with and without cytopenia(s)"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4651-5125","authenticated-orcid":false,"given":"Tariq","family":"Kewan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadil","family":"Zureigat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Pankaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-8163","authenticated-orcid":false,"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1792-5822","authenticated-orcid":false,"given":"Dragan","family":"Jevremovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5536-9011","authenticated-orcid":false,"given":"Patricia","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5134-7336","authenticated-orcid":false,"given":"Antoine N.","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasiya","family":"Matin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-3380","authenticated-orcid":false,"given":"Mehrdad","family":"Hefazi Torghabeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseema","family":"Gangat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5841-4105","authenticated-orcid":false,"given":"William","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3609-8404","authenticated-orcid":false,"given":"Hassan","family":"Alkhateeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Arana Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1673-1708","authenticated-orcid":false,"given":"James","family":"Foran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-6302","authenticated-orcid":false,"given":"Mark","family":"Litzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5359-336X","authenticated-orcid":false,"given":"Mithun Vinod","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-8593","authenticated-orcid":false,"given":"Kebede","family":"Begna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1548-918X","authenticated-orcid":false,"given":"Badar","family":"Talha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Kusne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-9887","authenticated-orcid":false,"given":"Abhishek A.","family":"Mangaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aref","family":"Al-Kali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaaren","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6998-662X","authenticated-orcid":false,"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"3140_CR1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36:1703\u201319.","journal-title":"Leukemia"},{"key":"3140_CR2","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200\u201328.","journal-title":"Blood"},{"key":"3140_CR3","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, Kahler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371:2477\u201387.","journal-title":"N Engl J Med"},{"key":"3140_CR4","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488\u201398.","journal-title":"N Engl J Med"},{"key":"3140_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377:111\u201321.","journal-title":"N Engl J Med"},{"key":"3140_CR6","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3324\/haematol.2019.222059","volume":"104","author":"P Valent","year":"2019","unstructured":"Valent P, Orazi A, Savona MR, Patnaik MM, Onida F, van de Loosdrecht AA, et al. Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions. Haematologica. 2019;104:1935\u201349.","journal-title":"Haematologica"},{"key":"3140_CR7","doi-asserted-by":"crossref","unstructured":"Weeks LD, Niroula A, Neuberg D, Wong W, Lindsley RC, Luskin M et al. Prediction of risk for myeloid malignancy in clonal hematopoiesis. NEJM Evid. 2023.","DOI":"10.1056\/EVIDoa2200310"},{"key":"3140_CR8","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood.2024024756","volume":"144","author":"Z Xie","year":"2024","unstructured":"Xie Z, Komrokji R, Al Ali N, Regelson A, Geyer S, Patel A, et al. Risk prediction for clonal cytopenia: multicenter real-world evidence. Blood. 2024;144:2033\u201344.","journal-title":"Blood"},{"key":"3140_CR9","doi-asserted-by":"crossref","unstructured":"Dunn WG, Sachs MC, Maggi M, Gu M, Quiros PM, Batta K et al. The prevalence and clinical significance of clonal monocytosis. Blood. 2026.","DOI":"10.1182\/blood.2025031883"},{"key":"3140_CR10","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/ajh.27271","volume":"99","author":"MM Patnaik","year":"2024","unstructured":"Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management. Am J Hematol. 2024;99:1142\u201365.","journal-title":"Am J Hematol"},{"key":"3140_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1182\/bloodadvances.2018024216","volume":"3","author":"H Awada","year":"2019","unstructured":"Awada H, Nagata Y, Goyal A, Asad MF, Patel B, Hirsch CM, et al. Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia. Blood Adv. 2019;3:339\u201349.","journal-title":"Blood Adv"},{"key":"3140_CR12","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1002\/sim.9023","volume":"40","author":"PC Austin","year":"2021","unstructured":"Austin PC, Steyerberg EW, Putter H. Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1. Stat Med. 2021;40:4200\u201312.","journal-title":"Stat Med"},{"key":"3140_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-024-02427-8","volume":"24","author":"P Liu","year":"2024","unstructured":"Liu P, Yuan H, Ning Y, Chakraborty B, Liu N, Peres MA. A modified and weighted Gower distance-based clustering analysis for mixed-type data: a simulation and empirical analyses. BMC Med Res Methodol. 2024;24:305.","journal-title":"BMC Med Res Methodol"},{"key":"3140_CR14","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1162\/089976604773717621","volume":"16","author":"T Lange","year":"2004","unstructured":"Lange T, Roth V, Braun ML, Buhmann JM. Stability-based validation of clustering solutions. Neural Comput. 2004;16:1299\u2013323.","journal-title":"Neural Comput"},{"key":"3140_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-110","volume":"11","author":"KK Nicodemus","year":"2010","unstructured":"Nicodemus KK, Malley JD, Strobl C, Ziegler A. The behaviour of random forest permutation-based variable importance measures under predictor correlation. BMC Bioinformatics. 2010;11:110.","journal-title":"BMC Bioinformatics"},{"key":"3140_CR16","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1182\/blood-2018-08-867333","volume":"133","author":"C Cargo","year":"2019","unstructured":"Cargo C, Cullen M, Taylor J, Short M, Glover P, Van Hoppe S, et al. The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis. Blood. 2019;133:1325\u201334.","journal-title":"Blood"},{"key":"3140_CR17","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/leu.2017.164","volume":"31","author":"BJ Patel","year":"2017","unstructured":"Patel BJ, Przychodzen B, Thota S, Radivoyevitch T, Visconte V, Kuzmanovic T, et al. Genomic determinants of chronic myelomonocytic leukemia. Leukemia. 2017;31:2815\u201323.","journal-title":"Leukemia"},{"key":"3140_CR18","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/modpathol.2017.45","volume":"30","author":"JT Geyer","year":"2017","unstructured":"Geyer JT, Tam W, Liu YC, Chen Z, Wang SA, Bueso-Ramos C, et al. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia. Mod Pathol. 2017;30:1213\u201322.","journal-title":"Mod Pathol"},{"key":"3140_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1182\/blood.2024027170","volume":"146","author":"A Tefferi","year":"2025","unstructured":"Tefferi A, Fathima S, Abdelmagid M, Alsugair AKA, Aperna F, Rezasoltani M, et al. BLAST: a globally applicable and molecularly versatile survival model for chronic myelomonocytic leukemia. Blood. 2025;146:874\u201386.","journal-title":"Blood"},{"key":"3140_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36906-1","volume":"14","author":"N Zioni","year":"2023","unstructured":"Zioni N, Bercovich AA, Chapal-Ilani N, Bacharach T, Rappoport N, Solomon A, et al. Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis. Nat Commun. 2023;14:2070.","journal-title":"Nat Commun"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03140-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:04:46Z","timestamp":1790640286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03140-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":20,"alternative-id":["3140"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03140-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following conflict of interests: MMP has received research funding from Kura Oncology, Stem Line Therapeutics, Epigenetix, Polaris, and Solutherapeutics. He has served on the advisory board for AstraZeneca, CITI, and GSK. AM has received research funding for trials at institutions from BMS, Gilead, Medexus, Solu Therapeutics, and Sanofi. ANS has received research funding paid to the institution from Gilead Sciences, Kura Oncology, and Chordia Therapeutics; it has received consulting fees paid to the institution from Novartis Pharmaceuticals. NG has served on the Advisory Board for Agios and DISC Medicine. MVS declares a research grant to its institution from AbbVie, Astellas, BMS\/Celgene, Kura Oncology, and MRKR Therapeutics.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}